As shown in the survival plot the overexpressed PRMT5 and FXR1 (SD > 1) alone (Supplementary Figure S5A and S5B) or in combination (Figure 8A), lead to poor patient survival in HNSCC and lung cancer patients. This evidence concerns the gene PRMT5 and lung cancer.